Country Correspondent: Paul Dourgnon
France’s 2019 Social Security Budget bill states that starting in 2020, patients who refuse generic drug prescriptions without a valid medical reason will have higher out-of-pocket costs for these drugs through the country’s public health insurance. In addition, doctors will have to provide a written justification when prescribing brand-name drugs instead of generics. Since 2013, 80 percent of brand-name drugs are substituted for generics in France. The public health insurance system is expected to save up to EUR 100 million (USD 113 million) from lower reimbursement of brand-name drugs and the resulting increases in generic drug consumption.